5-HT1D receptor

Assets acting on this target.

Class
Ergot alkaloid 5-HT1D receptor agonist (also binds other 5-HT, adrenergic and dopamine receptors)

By indication

5-HT1D receptor drugs compared

5 drugs, stage by indication
5 drugs acting on 5-HT1D receptor: developer, modality, furthest stage and stage in each indication. Furthest stage first.
DrugDeveloperModalityFurthest stageStage by indication
Dihydroergotamine (Atzumi)AtzumiShin Nippon Biomedical Laboratoriessmall moleculeApprovedApproved in Migraine
Dihydroergotamine mesylate (Brekiya)BrekiyaAmneal Pharmaceuticalssmall moleculeApprovedApproved in Migraine
Dihydroergotamine mesylate (D.H.E. 45)D.H.E. 45Bausch Healthsmall moleculeApprovedApproved in Migraine
Dihydroergotamine mesylate (Migranal)MigranalAdvanz Pharma, Bausch Healthsmall moleculeApprovedApproved in Migraine
Dihydroergotamine mesylate/Dipyrone/Caffeine (Cefaliv)CefalivAché Laboratórios Farmacêuticos S.A.Not recordedStage not recordedNot recorded

← all mechanisms